Crossmark

Left atrial appendage occlusion vs standard of care in high stroke risk atrial fibrillation patients ineligible for anticoagulation: COMPARE-LAAO

Crossref DOI link: https://doi.org/10.1007/s12471-025-02005-7

Published Online: 2025-12-16

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aarnink, Errol W. https://orcid.org/0000-0002-0189-8647
Huijboom, Marina F. M.

van der Kley, Frank

Folkeringa, Richard

de Groot, Joris R.

van der Voort, Pepijn H.

Blaauw, Yuri

Chaldoupi, Marisevi

Stevenhagen, Jeroen

Vlachojannis, George J.

van Mieghem, Nicolas M.

Swaans, Martin J.

van Dijk, Vincent F.

Dijkgraaf, Marcel G.

van Dijk, Ewoud J.

Tijssen, Jan G. P.

Boersma, Lucas V. A.
Funding

Funding for this research was provided by:

Zorginstituut Nederland (2020006340)
License Information

Text and Data Mining valid from 2025-12-16

Version of Record valid from 2025-12-16
More Information

Article History

Received: 17 March 2025

Accepted: 5 November 2025

First Online: 16 December 2025

Conflict of Interest

: J.R. de Groot reports institutional grants from the Dutch Heart Foundation/DCVA, ERA4Health PERSUADE consortium, Information Technology for European Advancement—ITEA4, Articure, Bayer, Boston Scientific, Daiichi Sankyo, Johnson&Johnseon, Medtronic, Philips, and honoraria from Articure, Bayer, Berlin Chemie, Daiichi Sankyo, Johnson&Johnson, Menarini, Medtronic, Novartis and Servier. Y. Blaauw reports a research grant and consulting fee from Boston Scientific. Fees go to the Cardiology department. N.M. van Mieghem reports grants from Abbott, Boston Scientific, Edwards Liefesciences, Medtronic, Meril, Pie Medical, PulseCath BV and Teleflex, and consulting fees from Abbott, Abiomed, Alleviant, Medical Inc., AncorValve, Anteris, Approxima Srl, Bolt Medical, Boston Scientific, Daiichi Sankyo, LUMA Vision, Materialise, Medtronic, Pie Medical, Polares, PulseCath BV and Siemens. M.J. Swaans reports consulting fees from Abbott Vascular, Bioventrix Inc., Boston Scientific, Cardiac Dimensions, Edwards Lifesciences, GE Healthcare, Medtronic, Philips Healthcare and Siemens Healthcare. J.R. de Groot , M.G. Dijkgraaf and L.V.A. Boersma are Editors of the Netherlands Heart Journal. M.G. Dijkgraaf has no other possible conflicts of interest to declare. L.V.A. Boersma reports consulting fees and honoraria from Boston Scientific. All fees go to the department. E.W. Aarnink, M.F.M. Huijboom, F. van der Kley, R. Folkeringa, P.H. van der Voort, J. Stevenhagen, G.J. Vlachojannis, M. Chaldoupi, V.F. van Dijk, E.J. van Dijk and J.G.P. Tijssen have no conflicts of interest related to this manuscript.

Document is current

Any future updates will be listed below